Is CBT or PRM a better buy right now?

Based on our latest analysis, CBT is currently the stronger investment candidate based on our comprehensive scoring model.

Does CBT or PRM have better growth?

Our analysis compares revenue and earnings growth. Check the 'Growth' section above to see which company is expanding faster. Typically, the stock with higher revenue growth rates is considered the better growth stock.

Which stock is cheaper: CBT or PRM?

We compare P/E ratios and other valuation metrics in the 'Valuation' section. The stock with the lower P/E ratio is generally considered 'cheaper' relative to its earnings, though growth prospects must also be considered.

Which is the better buy right now, CBT or PRM?

As of Nov 12, 2026, CBT scores higher in our model: CBT has an AI score of 47.6 versus 32.2 for PRM. CBT is currently in a Markdown technical phase and PRM is in a Neutral phase. Consider both scores and phases alongside your own risk tolerance.

What technical phase are CBT and PRM in?

CBT is in a Markdown phase (Sell / avoid) with an RSI of 42.6. PRM is in a Neutral phase (Hold) with an RSI of 62.4.

CBT vs PRM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 12, 2026

CBT

47.6

AI Score

CBT Wins

PRM

32.2

AI Score

Investment Advisor Scores

CBT

48score

Recommendation

HOLD

View Full Analysis

PRM

32score

Recommendation

SELL

View Full Analysis

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric	CBT	PRM	Winner
Revenue	728.74M	2.73B	CBT
Net Income	195.77M	147.00M	PRM
Gross Margin	55.9%	22.1%	PRM
Net Margin	26.9%	5.4%	PRM
Operating Income	285.92M	356.00M	CBT
ROE	14.7%	9.2%	PRM
ROA	5.8%	3.7%	PRM
Total Assets	3.40B	3.98B	CBT
Cash	115.91M	250.00M	CBT
Debt/Equity	0.91	0.52	CBT
Current Ratio	2.79	1.47	PRM
Free Cash Flow	42.30M	126.00M	CBT

Relative Price Performance (Last 90 Days)

CBT 1M: -4.3% · 3M: -16.3% PRM 1M: +11.5% · 3M: -9.2%

Current Technical Phase

CBT

Markdown

Sell / avoid

Price below a falling SMA50 (slope -5.7%), weak momentum, RSI 43

RSI (14): 42.6 · Price: $72.23

PRM

Neutral

Hold

Mixed signals - no dominant trend phase, RSI 62

RSI (14): 62.4 · Price: $30.67

Fundamentals Snapshot

Metric	CBT	PRM
Market Cap	—	—
Forward P/E	9.4	17.9
Trailing P/E	18.0	139.6
Revenue (TTM)	—	—
Revenue Growth	0.1%	0.2%
Gross Margin	0.2%	0.5%
Operating Margin	0.1%	1.1%
EPS	4.02	0.22
Dividend Yield	0.00%	—

Frequently Asked Questions

Based on our detailed analysis, CBT is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.

Related Analysis

CBT

PRM

Data derived from SEC EDGAR filings and Tradestie proprietary analysis. Last updated: Nov 12, 2026 03:41 UTC. Refresh Data

Tradestie